ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,675.29
1.08%
US Tech 100
19,073.60
-0.84%
다우존스 지수
41,964.63
0.92%
Bitcoin
85,223.25
-1.92%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Carisma Therapeutics Inc (CARM) 시세

Carisma Therapeutics Inc

Carisma Therapeutics Inc (CARM)

Carmanah Minerals Corp
Carrefour Property Development
0.42
0.0193
(4.82%)
마감 20 3월 5:00AM
15분 지연
0.42
0.00
( 0.00% )
시간외 단일가: 5:14PM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
0.42
매수가
0.42
매도가
0.43
거래량
3
0.00 일간 변동폭 0.00
0.38 52주 범위 2.66
market_cap
17.535M
전일 종가
0.42
개장가
-
최근 거래 시간
3
@
0.42
마지막 거래 시간
18:40:19
재정 규모
-
VWAP
-
평균 볼륨(3m)
306,792
발행 주식
41,750,109
배당수익률
-
주가수익률
-0.20
주당순이익(EPS)
-2.08
매출
14.92M
순이익
-86.88M

Carisma Therapeutics Inc 정보

Carisma Therapeutics Inc. is a clinical-stage cell therapy company. The Company is focused on utilizing the Company's macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The Company has created a comprehensive cell t... Carisma Therapeutics Inc. is a clinical-stage cell therapy company. The Company is focused on utilizing the Company's macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The Company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells. The Company's lead product candidate, CT-0508, is a Chimeric Antigen Receptor Macrophage (CAR-M) to be evaluated in a human clinical trial and is intended to treat solid tumors that overexpress HER2. The Company's second product candidate, CT-0525, is also intended to treat solid tumors that overexpress HER2, is in preclinical development. Beyond CT-0508 and CT-0525, the Company has a pipeline of cell therapy assets in various stages of pre-clinical development. The Company is also developing in vivo CAR-M gene therapies. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.carismatx.com
본부
Wilmington, Delaware, USA
설립됨
-
Carisma Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CARM. The last closing price for Carisma Therapeutics was US$0.42. Over the last year, Carisma Therapeutics shares have traded in a share price range of US$ 0.38 to US$ 2.66.

Carisma Therapeutics currently has 41,750,109 shares in issue. The market capitalisation of Carisma Therapeutics is US$17.54 million. Carisma Therapeutics has a price to earnings ratio (PE ratio) of -0.20.

CARM 최신 뉴스

추가 뉴스
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.00120.2865329512890.41880.4550.39511296680.41504401CS
4-0.06-12.50.480.49970.381467590.42507309CS
120.0235.793450881610.3970.61790.383067920.47839226CS
26-0.56-57.14285714290.981.130.382557540.60355549CS
52-1.89-81.81818181822.312.660.382717081.00893028CS
156-5.37-92.74611398965.799.76620.382455062.80417644CS
260-5.37-92.74611398965.799.76620.382455062.80417644CS

CARM - Frequently Asked Questions (FAQ)

What is the current Carisma Therapeutics share price?
The current share price of Carisma Therapeutics is US$ 0.42
How many Carisma Therapeutics shares are in issue?
Carisma Therapeutics has 41,750,109 shares in issue
What is the market cap of Carisma Therapeutics?
The market capitalisation of Carisma Therapeutics is USD 17.54M
What is the 1 year trading range for Carisma Therapeutics share price?
Carisma Therapeutics has traded in the range of US$ 0.38 to US$ 2.66 during the past year
What is the PE ratio of Carisma Therapeutics?
The price to earnings ratio of Carisma Therapeutics is -0.2
What is the cash to sales ratio of Carisma Therapeutics?
The cash to sales ratio of Carisma Therapeutics is 1.18
What is the reporting currency for Carisma Therapeutics?
Carisma Therapeutics reports financial results in USD
What is the latest annual turnover for Carisma Therapeutics?
The latest annual turnover of Carisma Therapeutics is USD 14.92M
What is the latest annual profit for Carisma Therapeutics?
The latest annual profit of Carisma Therapeutics is USD -86.88M
What is the registered address of Carisma Therapeutics?
The registered address for Carisma Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Carisma Therapeutics website address?
The website address for Carisma Therapeutics is www.carismatx.com
Which industry sector does Carisma Therapeutics operate in?
Carisma Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
SAGSAG Holdings Ltd
US$ 1.20
(77.78%)
8.63M
OPTNOptiNose Inc
US$ 9.60
(60.00%)
161.1k
LEELee Enterprises Inc
US$ 11.99
(36.72%)
14
IMGCIMG Inc
US$ 0.6427
(33.90%)
5.54M
IDYAIDEAYA Biosciences Inc
US$ 23.99
(31.74%)
59
TRUETrueCar Inc
US$ 0.7234
(-58.43%)
1
CSQCalamos Strategic Total Return Fund
US$ 10.01
(-39.52%)
1
ZCARZoomcar Holdings Inc
US$ 0.2149
(-29.98%)
129.33k
AKBAAkebia Therapeutics Inc
US$ 2.09
(-26.41%)
149.07k
NEHCNew Era Helium Inc
US$ 2.00
(-20.32%)
24
AGMHAGM Group Holdings Inc
US$ 0.09
(25.00%)
38.34M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.86
(-3.44%)
16.9M
BTOGBit Origin Ltd
US$ 0.3131
(18.20%)
10.8M
SAGSAG Holdings Ltd
US$ 1.19
(76.30%)
8.63M
IMGCIMG Inc
US$ 0.6428
(33.92%)
5.54M

CARM Discussion

게시물 보기
glenn1919 glenn1919 2 월 전
CARM...................................https://stockcharts.com/h-sc/ui?s=CARM&p=W&b=5&g=0&id=p86431144783
👍️0
PonkenPlonken PonkenPlonken 6 월 전
I appreciate you reaching out. I like to follow the money in bioland or predict where it might go. Hence i really like this. Their CAR M CD47 approach is not new and many wished for these trials. The risk however is huge hence no one bit this (monotherapy trial with safety as primary endpoint is almost random)

I am having a very close eye on this as they will share the first clinical data in q4. Any price increase prior might hint at things being right/a rally coming. The problem is, this is monotherapy only and not the one where they combine with the mRNA tech (which is likely where the good stuff is)

So down the road we will be getting some great hints here on whether this might be "THE next big thing" or not.... A LOT of targets nominated by them...
👍️0
jondoeuk jondoeuk 6 월 전
From this: “Without a doubt there's big biological risk here,” says Carisma CSO Michael Klichinsky. Researchers have yet to prove either the efficacy or the approvability of CAR macrophages. But solid tumours account for 90% of the cancer burden, making the possibility of activity in these settings with an in vivo reprogramming agent all the more appealing. “We’re going after a real unmet need,” he adds. https://www.nature.com/articles/d41573-024-00150-z
👍️0
Prestotic Prestotic 7 월 전
Vdog, your dog stock shedding another 8.33% today on a pathetic 2 million shares. Going to trips withou a contract soon. Hope you get this message. You could be in Carisma if only you listened.
👍️0
Prestotic Prestotic 7 월 전
Vdog has no Carisma Therapeutics. Losers like him love losers like VXIT. Carisma up 50 % in 2 weeks, Vxit down 50%. LOVE to say I TOLD YOU SO! How's your DD treating you JA
👍️0
Prestotic Prestotic 7 월 전
Eat shi* vdog
👍️0
Prestotic Prestotic 7 월 전
Another 50,000 getting accumulated/ covered @ $1.04. To the moon, soon.
👍️0
Prestotic Prestotic 7 월 전
No noise here because Carisma is not a penny stock. This has moved nicely off of the bottom of .80 from last week. Plus 20%. Positive results from phase 2 study will solidify deal with Moderna and get this back up to levels seen mid June. Today's action, including buy, buy, buy of 75000 shares at 3:30 pm shows accumulation, or at least some worried shorts covering. Looking for strong move up on phase 2 results.
👍️0
Prestotic Prestotic 7 월 전
No noise here because Carisma in not a penny stock. This has moved nicely off of the bottom of .80 from last week. Plus 20%. Positive results from phase 2 study will solidify deal with Moderna and get this back up to levels seen mid July. Today's action, including buy, buy, buy of 75000 shares around 2pm shows accumulation, or at least something worried shorts covering. Looking for strong move up on phase 2 results.
👍️0
CancunCharlie CancunCharlie 7 월 전
Is there anyone here?? No comments in over a month. I think this looks good, but I'm wondering why it's so quite here.
👍️0
PonkenPlonken PonkenPlonken 9 월 전
pretty strong
nice tech$
👍️0
glenn1919 glenn1919 9 월 전
CARM.......................https://stockcharts.com/h-sc/ui?s=CARM&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 9 월 전
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna
👍️0
Termite7 Termite7 10 월 전
Could it be CARM under $0.30 ....???.......Thanks!!!
👍️0
axelvento axelvento 10 월 전
$1.46 bouncer
👍️0
PonkenPlonken PonkenPlonken 11 월 전
https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-023-00537-x
MRNA provides the tech, 3bln + in biobucks and has not so distant private relative with TOP tier c suite.
👍️0
Monksdream Monksdream 12 월 전
CARM under $3
👍️0
mrplmer mrplmer 1 년 전
Whatever happened with their acquisition of Sesn Bio and their Bladder Cancer
👍️0
mrplmer mrplmer 1 년 전
Whatever happened with their acquisition of Sesn Bio and their Bladder Cancer
👍️0
81vette 81vette 1 년 전
1st higher high today and bid growing now,I got some 2.64,will see if dump continues or not
👍️0
81vette 81vette 1 년 전
Yea,distribution only so far today,I am watching for accumulation to start after this dumpathon,short interest went up 300% today also, 100k now,no sign of institutional buying yet,they currently hold 19%
👍️0
stock1ace1 stock1ace1 1 년 전
Red on news .. we no what that means lol
👍️0
81vette 81vette 1 년 전
Deal with Moderna for cancer cures,institutional might buy now lol,went up last time on this news,analysts target $9.50,short 2.45M,not optionable is good,gap filled down now,52 week low 2 weeks ago
👍️0

최근 히스토리

NASDAQ
CARM
Carisma Therapeutics
LSE
76UA
Natwest.m 24
LSE
0DOG
Azkoyen
LSE
44QY
Atlas Copco 26
TSX
CPH
Cipher Pharmaceuticals
LSE
22MI
Akademiska 48
NASDAQ
USIO
Usio
AQSE
PSRF.GB
Invesco Ftse Rafi Us 100...
LSE
44QR
Investec Bnk 24
LSE
0IZM
Abg Sundal Collier Holdi...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지